Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.
Cyclomics has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.
Cyclomics's investors include EISMEA, Oncode Oncology Bridge Fund, Myosotis Investments.
Cyclomics is headquartered in Utrecht, The Netherlands.
Cyclomics is a Dutch startup with ambition is to transform cancer care by enabling faster and more reliable diagnoses.
Cyclomics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cyclomics — Funding & Investors." VCBacked, January 7, 2026, https://www.vcbacked.co/company/cyclomics. Accessed July 20, 2026.
VCBacked. (2026). Cyclomics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/cyclomics
{{cite web |title=Cyclomics — Funding & Investors |url=https://www.vcbacked.co/company/cyclomics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated